Patients shouldnt assume a denial is final. If insurance does not cover medications like Wegovy or Zepbound, compounded semaglutide or tirzepatide may be considered
The lipid benefits of GLP-1 receptor agonists should be viewed as complementary rather than alternative to established cholesterol management strategies
The landmark review covering Thymosin 4 biology, cell migration, angiogenesis and tissue remodelling
According to a survey from Leger Healthcare, 8% of respondents are currently on a prescription GLP-1
But because food is staying in your stomach and digestive system for an extended period of time and the impact on certain receptors in the brain, it raises your risk for the most common gastrointestinal GLP-1 side effects, like nausea, vomiting, diarrhea, and constipation